Corn Faces Pressure into the Weekend
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Analysts Think Axsome Therapeutics Stock Could Soar 35% Over the Next 12 Months. Is the Stock a No-Brainer Buy?
Key PointsAxsome Therapeutics' revenue is growing at a good clip.
Why Wendy's Stock Flopped on Friday
An important franchisee has filed for bankruptcy protection.
3 Dividend Stocks to Buy and Hold for 10 Years
Key PointsPfizer has a deep pipeline that could help improve its approved lineup and financial results over the medium term.
